Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gossamer Bio Inc (GOSS)

Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 77,379
  • Shares Outstanding, K 234,696
  • Annual Sales, $ 48,470 K
  • Annual Income, $ -170,370 K
  • EBIT $ -171 M
  • EBITDA $ -176 M
  • 60-Month Beta 2.16
  • Price/Sales 1.67
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.75
  • Most Recent Earnings $-0.21 on 03/17/26
  • Next Earnings Date 05/21/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 152.13% (-24.72%)
  • Historical Volatility 125.52%
  • IV Percentile 65%
  • IV Rank 15.28%
  • IV High 633.32% on 02/20/26
  • IV Low 65.36% on 08/20/25
  • Expected Move (DTE 9) 0.0935 (26.91%)
  • Put/Call Vol Ratio 0.46
  • Today's Volume 54
  • Volume Avg (30-Day) 1,835
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 81,031
  • Open Int (30-Day) 225,667
  • Expected Range 0.2539 to 0.4409

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.18
  • Number of Estimates 5
  • High Estimate $-0.05
  • Low Estimate $-0.25
  • Prior Year $-0.16
  • Growth Rate Est. (year over year) -12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3200 +8.56%
on 04/07/26
0.5686 -38.90%
on 03/10/26
-0.1533 (-30.62%)
since 03/06/26
3-Month
0.3200 +8.56%
on 04/07/26
2.9990 -88.42%
on 01/22/26
-2.1526 (-86.10%)
since 01/08/26
52-Week
0.3200 +8.56%
on 04/07/26
3.8700 -91.02%
on 12/15/25
-0.4426 (-56.03%)
since 04/08/25

Most Recent Stories

More News
Deadline Approaching: Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Law Offices of Howard G. Smith reminds investors of the upcoming  June 1, 2026  deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Gossamer...

GOSS : 0.3474 (+5.37%)
GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Overstated Trial Prospects: Levi & Korsinsky

Promise vs. Reality: The Gossamer Bio PROSERA Performance Gap

GOSS : 0.3474 (+5.37%)
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Gossamer Bio, Inc. (GOSS) Shareholders To Inquire About Securities Fraud Class Action

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or...

GOSS : 0.3474 (+5.37%)
GOSS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Gossamer Bio, Inc. Securities Lawsuit -- The Gross Law Firm

NEW YORK , April 7, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Gossamer Bio, Inc. (NASDAQ: GOSS).

GOSS : 0.3474 (+5.37%)
Law Offices of Frank R. Cruz Encourages Gossamer Bio, Inc. (GOSS) Shareholders To Inquire About Securities Fraud Class Action

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Gossamer Bio, Inc. (“Gossamer” or the “Company”)...

GOSS : 0.3474 (+5.37%)
Law Offices of Howard G. Smith Encourages Gossamer Bio, Inc. (GOSS) Shareholders To Inquire About Securities Fraud Class Action

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Gossamer Bio, Inc. (“Gossamer” or the “Company”) (NASDAQ:  GOSS...

GOSS : 0.3474 (+5.37%)
Gossamer Bio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GOSS

LOS ANGELES , April 6, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Gossamer Bio, Inc. ("Gossamer" or "the Company") (NASDAQ: GOSS ) violations...

GOSS : 0.3474 (+5.37%)
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , April 6, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gossamer Bio, Inc. ("Gossamer"...

GOSS : 0.3474 (+5.37%)

Business Summary

Gossamer Bio Inc. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutics in the areas of immunology, inflammation and oncology. The company's product pipeline includes GB001, GB002, GB004, GB1275, Autoimmune program and Oncology...

See More

Key Turning Points

3rd Resistance Point 0.3765
2nd Resistance Point 0.3632
1st Resistance Point 0.3465
Last Price 0.3474
1st Support Level 0.3165
2nd Support Level 0.3032
3rd Support Level 0.2865

See More

52-Week High 3.8700
Fibonacci 61.8% 2.5139
Fibonacci 50% 2.0950
Fibonacci 38.2% 1.6761
Last Price 0.3474
52-Week Low 0.3200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.